PATIENT REPORTING OF ADVERSE DRUG REACTIONS IN POLAND AND THE NETHERLANDS: A COMPARISON OF TWO PHARMACOVIGILANCE APPROACHES AND THEIR IMPACT

Journal of Health Policy and Outcomes Research · Published 2026-06-06 · DOI 10.7365/jhpor.2026.1.4

Free full text

Authors (2)

Katarzyna Opoczyńska, Anna Staniszewska

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Opoczyńska, K., Staniszewska, A. (2026). PATIENT REPORTING OF ADVERSE DRUG REACTIONS IN POLAND AND THE NETHERLANDS: A COMPARISON OF TWO PHARMACOVIGILANCE APPROACHES AND THEIR IMPACT. Journal of Health Policy and Outcomes Research. https://doi.org/10.7365/jhpor.2026.1.4

Related articles

• The impact of the SARS-CoV-2 virus pandemic on the hygiene habits of the Poles · Journal of Health Policy and Outcomes Research · 2021 · Same journal
• Is disease-modifying therapy use in multiple sclerosis a risk factor during the COVID-19 pandemic? A large cohort study · Journal of Health Policy and Outcomes Research · 2024 · Same journal
• Potential in the treatment of neovascular Age-related Macular Degeneration and Diabetic Macular Edema in Poland. The population needs and access to therapy · Journal of Health Policy and Outcomes Research · 2024 · Same journal
• Analysis of the Health Care System in Estonia · Journal of Health Policy and Outcomes Research · 2025 · Same journal
• Budget Impact Analysis for Proton Beam Therapy for pediatric population in Poland · Journal of Health Policy and Outcomes Research · 2023 · Same journal
• Incidence and prevalence of psychotic disorders, a county population study of Tirana hospital admissions · Journal of Health Policy and Outcomes Research · 2023 · Same journal
• Drug Utilization Pattern and Pharmacoeconomics of Multivitamins Prescribed to Pediatric Patients at a Tertiary Care Hospital · Journal of Health Policy and Outcomes Research · 2025 · Same journal
• Drug Program Resource Analysis: "TREATMENT OF CHRONIC SPONTANEOUS URTICARIA (ICD-10 L50.1) · Journal of Health Policy and Outcomes Research · 2021 · Same journal
• The Future of Health Insurance in India: A Case of Ayushman Bharat · Journal of Health Policy and Outcomes Research · 2024 · Same journal
• SGLT2 inhibitors and cardioprotection. Literature review and real-world data from Poland · Journal of Health Policy and Outcomes Research · 2022 · Same journal